Mikko Hakola

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial

Timo Möttönen, Pekka Hannonen, Marjatta Leirisalo‐Repo et al. · The Lancet · 1999 · 865 citations

Rheumatoid Disorder, Rheumatology, Medicine +10

Sulfasalazine in early rheumatoid arthritis. A 48‐week double‐blind, prospective, placebo‐controlled study

Pekka Hannonen, Timo Möttönen, Mikko Hakola et al. · Arthritis & Rheumatism · 1993 · 137 citations

Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis.

Heidi Mäkinen, Hannu Kautiainen, Pekka Hannonen et al. · PubMed · 2007 · 126 citations

Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial

Vappu Rantalaiho, Hannu Kautiainen, Markku Korpela et al. · Annals of the Rheumatic Diseases · 2013 · 54 citations

Urinary Neopterin Index as a Measure of Rheumatoid Activity

Pekka Hannonen, S Tikanoja, Mikko Hakola et al. · Scandinavian Journal of Rheumatology · 1986 · 22 citations

Inflammation, Rheumatology, Urinary Neopterin Index +13